TG Therapeutics (TGTX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

36.840
+2.420+7.03%

Trading Mar 4 10:48 ET

5.79BMarket Cap245.60P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $10 to $55
Moomoo News08:00 ET · Ratings
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), BioLife Solutions (BLFS) and Surgery Partners (SGRY)
TipRanks07:30 ET · Ratings
Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns
TipRanks06:37 ET
TG Therapeutics Analyst Ratings
Benzinga06:33 ET · Ratings
Strong Financial Performance and Promising Outlook Drive Buy Rating for TG Therapeutics
TipRanks06:21 ET · Ratings
Q4 2024 TG Therapeutics Inc Earnings Call
Yahoo Finance00:42 ET

Comments

Yesterday 20:08

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

$TG Therapeutics (TGTX.US)$
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

$TG Therapeutics (TGTX.US)$
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

strong performing

$TG Therapeutics (TGTX.US)$ 42

1

Nov 29, 2024 09:55

Share Your Profit/Loss

15

Nov 29, 2024 07:16

$TG Therapeutics (TGTX.US)$

2

Read more